硕肯生物硕肯生物Soken.bio
查看试用产品 →开放浏览 · 登录后申请
抗人 MAEA 抗体对
试剂盒

抗人 MAEA 抗体对

01AB00895

Macrophage erythroblast attacher, E3 ubiquitin ligase (MAEA) is a multifunctional protein that serves as a core component of the CTLH E3 ubiquitin-protein ligase complex, selectively accepting ubiquitin from UBE2H to mediate ubiquitination and subsequent proteasomal degradation of transcription factor HBP1. MAEA plays a crucial role in erythropoiesis by mediating the attachment of erythroblasts to macrophages, promoting terminal maturation and enucleation of erythrocytes while inhibiting erythroid cell apoptosis. It participates in erythroblastic island formation, the functional unit of definitive erythropoiesis, and associates with F-actin to regulate actin distribution in erythroblasts and macrophages. Recent studies have shown MAEA is essential for hematopoietic stem cell (HSC) maintenance and lymphoid potential, with its deletion in mice severely impairing HSC quiescence and leading to a lethal myeloproliferative syndrome. MAEA has been associated with several diseases including type 2 diabetes mellitus, various hemoglobinopathies (hemoglobin D and E diseases), hereditary elliptocytosis, myelofibrosis, and cancer.

Human
规格起售价
登录后可查看

技术参数

靶点基因名
MAEA
基因别名
EMP
蛋白别名
macrophage erythroblast attacher, E3 ubiquitin ligase; MAEA
UniProt
Q7L5Y9
物种
Human

产品详情

靶点名称
MAEA
蛋白名称
macrophage erythroblast attacher, E3 ubiquitin ligase
蛋白别名
E3 ubiquitin-protein transferase MAEA; Cell proliferation-inducing gene 5 protein; Erythroblast macrophage protein; Human lung cancer oncogene 10 protein; HLC-10; Macrophage erythroblast attacher; P44EMLP
靶点基因名
MAEA
基因别名
EMP
UniProt
Q7L5Y9
来源物种
Homo sapiens (Human)
物种反应性
Human

背景介绍

Macrophage erythroblast attacher, E3 ubiquitin ligase (MAEA) is a multifunctional protein that serves as a core component of the CTLH E3 ubiquitin-protein ligase complex, selectively accepting ubiquitin from UBE2H to mediate ubiquitination and subsequent proteasomal degradation of transcription factor HBP1. MAEA plays a crucial role in erythropoiesis by mediating the attachment of erythroblasts to macrophages, promoting terminal maturation and enucleation of erythrocytes while inhibiting erythroid cell apoptosis. It participates in erythroblastic island formation, the functional unit of definitive erythropoiesis, and associates with F-actin to regulate actin distribution in erythroblasts and macrophages. Recent studies have shown MAEA is essential for hematopoietic stem cell (HSC) maintenance and lymphoid potential, with its deletion in mice severely impairing HSC quiescence and leading to a lethal myeloproliferative syndrome. MAEA has been associated with several diseases including type 2 diabetes mellitus, various hemoglobinopathies (hemoglobin D and E diseases), hereditary elliptocytosis, myelofibrosis, and cancer.